https://www.iltempo.it/comunicati-adn-kronos/2019/04/01/news/fda-approves-mavenclad-cladribine-tablets-as-first-and-only-short-course-oral-treatment-for-relapsing-remitting-and-active-secondary-progressive-multiple-sclerosis-1126294/2026-09-23T09:06:14.612Zalways0.5https://www.iltempo.it/la-bilancia-di-re-salomone/2019/04/01/news/la-lazio-batte-l-inter-e-vede-la-champions-1126219/2026-09-23T09:06:07.594Zalways0.5https://iltempo.it/resizer/v2/HU2V2BCWAJO77B4NQ4EBTVJUCE.jpg?auth=2181b6fb21f10761fa29c28e3a670fe0ffb58d292a7c7cadd75c3b357d120894&smart=true&width=1200&height=900